| Stage | AMGN | % of rev | BCRX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10.4B | 100.00% | $180M | 100.00% | AMGN ×57.49 |
| Gross profit | $7.6B | 73.10% | $179M | 99.13% | BCRX +26.0pp |
| Operating income | $3.7B | 35.79% | $53M | 29.58% | AMGN +6.2pp |
| Pre-tax income | $4.7B | 45.21% | $39M | 21.40% | AMGN +23.8pp |
| Net income | $3.9B | 37.28% | $38M | 21.03% | AMGN +16.2pp |
| Stage | AMGN | BCRX | Gap · A − B |
|---|---|---|---|
| Revenue | $10.4B100.00% | $180M100.00% | AMGN ×57.49 |
| Gross profit | 73.10%$7.6B | 99.13%$179M | BCRX +26.0pp |
| Operating income | 35.79%$3.7B | 29.58%$53M | AMGN +6.2pp |
| Pre-tax income | 45.21%$4.7B | 21.40%$39M | AMGN +23.8pp |
| Net income |
| 37.28%$3.9B |
| 21.03%$38M |
| AMGN +16.2pp |
No shared counterparties.